Persistent hypoglycemia as an early, atypical presentation of hepatocellular carcinoma: A case report and systematic review of the literature

Tsai,Chen‑Yen; Chou,Shou‑Chu; Liu,Hsien‑Ta; Lin,Jiunn‑Diann; Lin,Ying‑Chin

doi:10.3892/ol.2014.2365

October 2014 Volume 8 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October 2014 Volume 8 Issue 4

Full Size Image

Case Report

Persistent hypoglycemia as an early, atypical presentation of hepatocellular carcinoma: A case report and systematic review of the literature

Authors:
- Chen‑Yen Tsai
- Shou‑Chu Chou
- Hsien‑Ta Liu
- Jiunn‑Diann Lin
- Ying‑Chin Lin
View Affiliations / Copyright

Affiliations: Department of Family Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei 23561, Taiwan, R.O.C., Department of Endocrinology and Metabolism, Shuang Ho Hospital, Taipei Medical University, New Taipei 23561, Taiwan, R.O.C.
Pages: 1810-1814
|
Published online on: July 18, 2014

https://doi.org/10.3892/ol.2014.2365
Expand metrics +

Abstract

The current study presents a case of persistent hypoglycemia as the initial manifestation of advanced hepatocellular carcinoma (HCC), as well as a systematic review of the management of hypoglycemia associated with HCC. A 42‑year‑old female presented with loss of consciousness and a blood glucose level of 30 mg/dl (normal range, 80‑140 mg/dl). Abdominal ultrasound and computed tomography were performed to investigate tenderness in the right upper quadrant, and the results revealed a hepatic mass of 15 cm in diameter, with metastasis. A diagnosis of insulinoma was ruled out by examining the insulin level. Prednisolone treatment was ineffective for relieving the persistent hypoglycemia, however, a single dose of palliative radiotherapy reduced the hypoglycemic episodes to once monthly. Due to the advanced disease, the patient refused further treatment, with the exception of a palliative therapy with glucose fluid. The patient succumbed to pneumonia with sepsis. A systematic review of the literature indicated that steroids were the most commonly used drug for hypoglycemia associated with HCC, however, in the majority of cases no effect was noted as observed in this study. Cytoreduction by surgery or systemic chemotherapy has been the most effective treatment. Although rare, hypoglycemia may be the initial symptom of HCC. Cytoreduction is the most effective method of treating hypoglycemia associated with HCC.

View Figures

View References

1	Saigal S, Nandeesh HP, Malhotra V and Sarin SK: A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol. 93:1380–1381. 1998.
2	Kahn CR: The riddle of tumour hypoglycaemia revisited. Clin Endocrinol Metab. 9:335–360. 1980.
3	Yeung RT: Hypoglycemia in hepatocellular carcinoma: a review. Hong Kong Med J. 3:297–301. 1997.
4	The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care Glasgow coma scale score. J Neurotrauma. 17:563–571. 2000.
5	McFadzean AJ and Yeung TT: Hypoglycemia in primary carcinoma of the liver. AMA Arch Intern Med. 98:720–731. 1956.
6	Klein H and Klein SP: Spontaneous hypoglycemia associated with massive hepatoma; a review of current concepts and report of a case. AMA Arch Intern Med. 103:273–278. 1959.
7	Schonfeld A, Babbott D and Gundersen K: Hypoglycemia and polycythemia associated with primary hepatoma. N Engl J Med. 265:231–233. 1961.
8	Wing JR, Panz VR, Joffe BI, Kalk WJ, Seftel HC, Zapf J and Kew MC: Hypoglycemia in hepatocellular carcinoma: failure of short-term growth hormone administration to reduce enhanced glucose requirements. Metabolism. 40:508–512. 1991.
9	Yonei Y, Tanaka M, Ozawa Y, Miyazaki K, Tsukada N, Inada S, Inagaki Y, Miyamoto K, Suzuki O, Okawa H, et al: Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors. Liver. 12:90–93. 1992.
10	Hoff AO and Vassilopoulou-Sellin R: The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer. 82:1585–1592. 1998.
11	Thipaporn T, Bubpha P and Varaphon V: Hepatocellular carcinoma with persistent hypoglycemia: successful treatment with corticosteroid and frequent high carbohydrate intake. J Med Assoc Thai. 88:1941–1946. 2005.
12	Nikeghbalian S, Bananzadeh A and Yarmohammadi H: Hypoglycemia, the first presenting sign of hepatocellular carcinoma. Saudi Med J. 27:387–388. 2006.
13	Kampitak T: Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin. Cancer Chemother Pharmacol. 62:929–930. 2008.
14	Matsuyama M, Sugiura S, Kakita A, Sato Y and Kuroda M: Hepatocellular carcinoma arising from ectopic liver tissue in the spleen producing insulin-like growth factor II. Pathol Res Pract. 207:124–126. 2011.
15	Benn JJ, Firth RG and Sönksen PH: Metabolic effects of an insulin-like factor causing hypoglycaemia in a patient with a haemangiopericytoma. Clin Endocrinol (Oxf). 32:769–780. 1990.
16	McFadzean AJ and Yeung RT: Further observations on hypoglycaemia in hepatocellular carcinoma. Am J Med. 47:220–235. 1969.
17	Di Bisceglie AM: Malignant neoplasms of the liver. Schiff’s Diseases of the Liver. Schiff ER, Sorrell MF and Maddrey WC: 8th edition. Lippincott-Raven; New York, NY: pp. 1288–1289. 1999
18	Le Roith D: Tumor-induced hypoglycemia. N Engl J Med. 341:757–758. 1999.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Persistent hypoglycemia as an early, atypical presentation of hepatocellular carcinoma: A case report and systematic review of the literature

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles